Sigal Aviel
Directeur des opérations chez PAINREFORM LTD.
Postes actifs de Sigal Aviel
Sociétés | Poste | Début | Fin |
---|---|---|---|
PAINREFORM LTD. | Directeur des opérations | 01/01/2014 | - |
Historique de carrière de Sigal Aviel
Anciens postes connus de Sigal Aviel
Sociétés | Poste | Début | Fin |
---|---|---|---|
MEDIWOUND LTD. | Directeur Technique/Scientifique/R&D | 01/03/2013 | 12/05/2014 |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | Directeur Technique/Scientifique/R&D | 01/01/2011 | 01/01/2013 |
Conseiller Juridique Général | 01/01/2011 | 01/01/2013 | |
PROTALIX BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2005 | 01/10/2010 |
Formation de Sigal Aviel
Kellogg School of Management | Masters Business Admin |
Duke University School of Medicine | Doctorate Degree |
Tel-Aviv University | Undergraduate Degree |
Statistiques
Internationale
Israël | 5 |
Etats-Unis | 4 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Chief Operating Officer | 1 |
General Counsel | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
MEDIWOUND LTD. | Health Technology |
PAINREFORM LTD. | Health Technology |
PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | Health Technology |
- Bourse
- Insiders
- Sigal Aviel
- Expérience